Dosing optimization of CCR4 immunotoxin for improved depletion of CCR4+ Treg in nonhuman primates
Recently, we have developed a diphtheria toxin‐based recombinant anti‐human CCR4 immunotoxin for targeting CCR4+ tumors and Tregs. In this study, we further optimized the dosing schedule for improved CCR4+ Treg depletion. We have demonstrated that up to a 90% depletion was achieved and the depletion...
Main Authors: | Zhaohui Wang, Nathan J. Louras, Alexandre G. Lellouch, Shannon G. Pratts, Huiping Zhang, Haoyu Wang, Christene A. Huang, Curtis L. Cetrulo Jr, Joren C. Madsen, David H. Sachs, Zhirui Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-08-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12331 |
Similar Items
-
Bispecific human IL2‐CCR4 immunotoxin targets human cutaneous T‐cell lymphoma
by: Haoyu Wang, et al.
Published: (2020-05-01) -
A review on the types of immunotoxins and their use in cancer treatment: review article
by: Saber Soltani, et al.
Published: (2018-04-01) -
Immunotoxins: The Role of the Toxin
by: David FitzGerald, et al.
Published: (2013-08-01) -
Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
by: Herman D. Lim, et al.
Published: (2021-04-01) -
CCR3, CCR4, CCR5, and CXCR3 expression in peripheral blood CD4+ lymphocytes in gastric cancer patients
by: Alireza Andalib, et al.
Published: (2013-01-01)